Performance of Cepheid® Xpert MTB/RIF® and TB-Biochip® MDR in two regions of Russia with a high prevalence of drug-resistant tuberculosis

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 32, Issue 6, 2013, Pages 735-743

  Kurbatova, E V ^a   Kaminski, D A ^a   Erokhin, V V ^b   Volchenkov, G V ^c   Andreevskaya, S N ^b   Chernousova, L N ^b   Demikhova, O V ^b   Ershova, J V ^a   Kaunetis, N V ^c   Kuznetsova, T A ^c   Larionova, E E ^b   Smirnova, T G ^b   Somova, T R ^c   Vasilieva, I A ^b   Vorobieva, A V ^b   Zolkina, S S ^c   Cegielski, J P ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^c Oblast TB Dispensary   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; CULTURE MEDIUM; DIAGNOSTIC ACCURACY; DIAGNOSTIC EQUIPMENT; DIAGNOSTIC TEST ACCURACY STUDY; DRUG RESISTANT TUBERCULOSIS; HUMAN; INTERMETHOD COMPARISON; LOEWENSTEIN MEDIUM; MAJOR CLINICAL STUDY; MICROSCOPY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RUSSIAN FEDERATION; SENSITIVITY AND SPECIFICITY; SPUTUM CULTURE; VALIDATION STUDY;

ADULT; BACTERIOLOGICAL TECHNIQUES; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; REPRODUCIBILITY OF RESULTS; RUSSIA; SENSITIVITY AND SPECIFICITY; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84878240376     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-012-1798-0     Document Type: Article

References (27)

1. World Health Organization (WHO) (2011) Global tuberculosis control 2011. WHO report. WHO, Geneva, Switzerland
2. Institute of Medicine (US) Forum on Drug Discovery, Development, and Translation; Russian Academy of Medical Science (2011) The new profile of drug-resistant tuberculosis in Russia: a global and local perspective: summary of a joint workshop. National Academy of Sciences, Washington DC
3. Gryadunov D, Mikhailovich V, Lapa S, Roudinskii N, Donnikov M, Pan'kov S et al (2005) Evaluation of hybridisation on oligonucleotide microarrays for analysis of drug-resistant Mycobacterium tuberculosis. Clin Microbiol Infect 11:531-539
4. Mikhailovich V, Lapa S, Gryadunov D, Sobolev A, Strizhkov B, Chernyh N et al (2001) Identification of rifampin-resistant Mycobacterium tuberculosis strains by hybridization, PCR, and ligase detection reaction on oligonucleotide microchips. J Clin Microbiol 39:2531-2540
5. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F et al (2010) Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 363:1005-1015
6. Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R et al (2011) Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 377:1495-1505
7. Kent PT, Kubica GP (1985) Public health mycobacteriology: a guide for the level III laboratory. Centers for Disease Control (CDC), Atlanta
8. World Health Organization (WHO) (1998) Laboratory services in tuberculosis control. Part II: microscopy. WHO, Geneva, Switzerland
9. Yu MC, Chen HY, Wu MH, Huang WL, Kuo YM, Yu FL et al (2011) Evaluation of the rapid MGIT TBc identification test for culture confirmation of Mycobacterium tuberculosis complex strain detection. J Clin Microbiol 49:802-807
10. Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM, van der Noordaa J (1990) Rapid and simple method for purification of nucleic acids. J Clin Microbiol 28:495-503
11. Ruiz M, Torres MJ, Llanos AC, Arroyo A, Palomares JC, Aznar J (2004) Direct detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis in auramine-rhodamine-positive sputum specimens by real-time PCR. J Clin Microbiol 42:1585-1589
12. Siddiqi SH, Ruesch-Gerdes S (2006) MGIT procedure manual. For BACTEC MGIT 960 TB system. Becton Dickinson, Franklin Lakes
13. Heifets LB (1991) Drug susceptibility tests in the management of chemotherapy of tuberculosis. In: Heifets LB (ed) Drug susceptibility in the chemotherapy of mycobacterial infections. CRC Press, Boca Raton, pp 89-121
14. Chang K, Lu W, Wang J, Zhang K, Jia S, Li F et al (2012) Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta-analysis. J Infect 64:580-588
15. Lawn SD, Brooks SV, Kranzer K, Nicol MP, Whitelaw A, Vogt M et al (2011) Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study. PLoS Med 8:e1001067
16. Nicol MP, Workman L, Isaacs W, Munro J, Black F, Eley B et al (2011) Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study. Lancet Infect Dis 11:819-824
17. Marlowe EM, Novak-Weekley SM, Cumpio J, Sharp SE, Momeny MA, Babst A et al (2011) Evaluation of the Cepheid Xpert MTB/RIF assay for direct detection of Mycobacterium tuberculosis complex in respiratory specimens. J Clin Microbiol 49:1621-1623
18. Armand S, Vanhuls P, Delcroix G, Courcol R, Lemaître N (2011) Comparison of the Xpert MTB/RIF test with an IS6110-TaqMan real-time PCR assay for direct detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens. J Clin Microbiol 49:1772-1776
19. Apfalter P, Reischl U, Hammerschlag MR (2005) In-house nucleic acid amplification assays in research: how much quality control is needed before one can rely upon the results? J Clin Microbiol 43:5835-5841
20. Noordhoek GT, van Embden JD, Kolk AH (1996) Reliability of nucleic acid amplification for detection of Mycobacterium tuberculosis: an international collaborative quality control study among 30 laboratories. J Clin Microbiol 34:2522-2525
21. Scott LE, McCarthy K, Gous N, Nduna M, Van Rie A, Sanne I et al (2011) Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study. PLoS Med 8:e1001061
22. Theron G, Peter J, van Zyl-Smit R, Mishra H, Streicher E, Murray S et al (2011) Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am J Respir Crit Care Med 184:132-140
23. Kurbatova EV, Cavanaugh JS, Shah NS, Wright A, Kim H, Metchock B et al (2012) Rifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugs. Int J Tuberc Lung Dis 16:355-357
24. Smith SE, Kurbatova EV, Cavanaugh JS, Cegielski JP (2012) Global isoniazid resistance patterns in rifampin-resistant and rifampin-susceptible tuberculosis. Int J Tuberc Lung Dis 16:203-205
25. Caoili JC, Mayorova A, Sikes D, Hickman L, Plikaytis BB, Shinnick TM (2006) Evaluation of the TB-Biochip oligonucleotide microarray system for rapid detection of rifampin resistance in Mycobacterium tuberculosis. J Clin Microbiol 44:2378-2381
26. Isakova ZhT (2008) Fast identification of rifampicin-and isoniazid resistance of M. Tuberculosis strains by the "TB-biochip" test system. Georgian Med News (158):15-19
27. Isakova ZhT (2009) Practical value of the TB-biochip MDR test system in the rapid identification of multidrug-resistant M. tuberculosis strains. Klin Lab Diagn (2):50-51